Monoclonal antibody to DR4 (Clone: ABM1B11 ) FITC Conjugated
Artikelnummer:
ABI-10-1002-F
Hersteller Artikelnummer:
10-1002-F
Alternativnummer:
ABI-10-1002-F-100UG
Hersteller:
Abeomics
Wirt:
Mouse
Kategorie:
Antikörper
Applikation:
FACS
Spezies Reaktivität:
Human
Immunogen:
A partial length recombinant human DR4 protein (amino acids 2-203 was used as an immunogen for this antibody.
Konjugation:
FITC
Alternative Synonym:
TNFRSF10A||APO2||DR4||TRAILR1
Death receptor 4 (DR4) or TRAIL-R1, a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that triggers the apoptotic machinery upon binding to its ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). DR4 is expressed in most of human tissues including spleen, peripheral blood leukocytes, small intestine and thymus. DR4 expression is enhanced by DNA damage whether induced by ionizing radiation or by chemotherapeutic agents. On binding DR4, TRAIL induces cell death via caspase-dependent apoptosis. DR4 mediate oligomeric Abeta induction of extrinsic apoptotic pathways in human microvascular cerebral endothelial cells with activation of both caspase-8 and caspase-9. It is considered a promising molecular target for cancer therapy.
Fig.1: Intracellular FLOW analysis of Jurkat cells using 0.5 µg of antibody. Red represents FITC conjugated DR4 antibody 10-1002-F(Clone: ABM1B11). Green represents FITC conjugated mouse IgG1 isotope control (ABEOMICS) .
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
